UNLIKELY LEADERS: THE BATTLE OF DEVELOPING COUNTRIES TO ACCESS PATENTED MEDICATIONS
LÍDERES IMPROVÁVEIS: A BATALHA DOS PAÍSES EM DESENVOLVIMENTO PELO ACESSO A MEDICAMENTOS PATENTEADOS
UNLIKELY LEADERS: THE BATTLE OF DEVELOPING COUNTRIES TO ACCESS PATENTED MEDICATIONS
LÍDERES IMPROVÁVEIS: A BATALHA DOS PAÍSES EM DESENVOLVIMENTO PELO ACESSO A MEDICAMENTOS PATENTEADOS
- 196 pages
- Brazil
- Editora FGV
- 2017
In negotiations with large laboratories, governments of large non-innovative countries would have greater bargaining power than the governments of the innovative giants among emerging countries. How is this possible? The answer is that only large non-innovative countries can employ a strategy to overcome patent medication protection under the TRIPS Agreement.
- UNLIKELY LEADERS: THE BATTLE OF DEVELOPING COUNTRIES TO ACCESS PATENTED MEDICATIONS
- Bruno Meyerhof Salama , Daniel Benoliel
- Fundação Getulio Vargas
- Available Worldwide
- Portuguese
- Printed, Electronic
-
- 978-852-2519-23-1
- Yes
-
- Juliana Demier Costa
- Juliana.costa@fgv.br
- +55 (21) 3799–4429